
|Articles|January 1, 2003
Technological advances boost hope for growth in refractive market
Author(s)Cheryl Guttman
Those with moderate myopia, hyperopia are potential candidates for vision correction surgery
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
3
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
4
Avisi Technologies treats first patient in SAPPHIRE trial for glaucoma
5















































.png)


